City
Epaper

How quickly will India's first COVID-19 vaccine Covaxin hit the market

By Lokmat English Desk | Updated: July 2, 2020 16:58 IST

Open in App
1 / 9
Research on the coronavirus vaccine is ongoing around the world. Meanwhile, good news is coming from India. The first coronavirus vaccine is being developed in India. Human testing of the vaccine will begin soon. But everyone is wondering when this vaccine will be available in the market.
2 / 9
It usually takes 8 to 10 years for the vaccine to reach the people. The first phase of the vaccine is tested on 1,000 to 3,000 people. This process takes a period of two years to complete. 15,000 to 30,000 in the subsequent phase.
3 / 9
The vaccine is then tested by an authorized organization. But if the vaccine is to be tested as soon as possible, it is tested on 50 to 500 people. This takes a period of 4 months.
4 / 9
Doses of the vaccine trial are then prepared. The test is performed on 500 to 100 people. It takes a period of 4 months.
5 / 9
Phase III testing is performed on different genetic grounds. This test depends on the prevalence of the disease and the government's recommendation. The test is performed on 10,000 to 50,000 people. The time taken depends on the dose of the vaccine. Usually 4 to 2 months.
6 / 9
Regulatory bodies have approved the first, second and third phase tests for the coronavirus vaccine. The third stage depends on the results of the first and second stages of the vaccine.
7 / 9
The results of the vaccine are then sent to regulatory bodies for examination and verification. It takes a period of six months.
8 / 9
Bharat Biotech has not yet set a date for the vaccine. The corona vaccine is expected to be available by the end of 2021.
9 / 9
According to the World Health Organization, 150 vaccines are now in various stages. 10 of these vaccines are now in the advanced stage.
Tags: Coronavirus VaccineCovaxinCoronavirus
Open in App

Related Stories

TechnologyNew Covid Wave Could Peak by August-End in South Korea; Government Strengthens Response Measures

HealthCOVID-19: Only 2% of Patients Develop Autoantibodies After Recovery, Study Reveals

HealthAfter Covishield, BHU Study Reveals Side Effects of Covaxin; Including Hair Loss, Skin Issues, and Menstrual Irregularities

InternationalAstraZeneca Withdraws COVID-19 Vaccine Globally Days After Side Effect Row, Firm Says Decision ‘Commercial’

HealthGood News! Scientists Develop All-in-One Vaccine Effective Against Current and Future Coronavirus Variants

Health Realted Stories

HealthIndia and Maldives strengthen healthcare partnership

HealthHeart rhythm disorder traces to bacterium lurking in gums: Study

HealthStudy shows weight-loss drugs can cut alcohol intake by almost two-thirds

HealthThis cholesterol pill may fight high risk of heart attack, stroke: Study

HealthIndia continues to witness significant improvement in key maternal, child health indicators: Report